Literature DB >> 24908160

Analytical approaches in microRNA therapeutics.

Sandor Batkai1, Thomas Thum2.   

Abstract

MicroRNAs are non-coding oligonucleotides with regulatory roles in virtually all biological processes. Deregulation of microRNAs lead to impaired cellular function and disease development. Thus, microRNAs are of potential diagnostic and therapeutic relevance. Several technology platforms are currently available for quantitative microRNA analysis and profiling, including the most extensively used PCR-based methods. Each of these technologies has its own advantages and limitations. Mass spectrometry combines low-level detectability with high selectivity and has been used for oligonucleotide sequence analysis. Its use for native microRNA analysis has been limited due to the very low abundance and chemical similarity of microRNAs. However, with the advancement of technology, this analytical method has become a powerful complementary tool for comprehensive analysis of native and synthetic microRNAs. This brief review highlights current developments in the field of microRNA analytics, detection techniques for extracellular microRNAs, their synthetic inhibitors, and the dynamics of their interactions.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarker; Functional assay; Liquid chromatography–mass spectrometry; MicroRNA; Oligonucleotide; Purification

Mesh:

Substances:

Year:  2014        PMID: 24908160     DOI: 10.1016/j.jchromb.2014.03.027

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy.

Authors:  Anselm A Derda; Sabrina Thum; Johan M Lorenzen; Udo Bavendiek; Joerg Heineke; Britta Keyser; Manfred Stuhrmann; Raymond C Givens; Peter J Kennel; P Christian Schulze; Julian D Widder; Johann Bauersachs; Thomas Thum
Journal:  Int J Cardiol       Date:  2015-06-05       Impact factor: 4.164

Review 2.  Liquid Biomarkers for Pediatric Brain Tumors: Biological Features, Advantages and Perspectives.

Authors:  Sibylle Madlener; Johannes Gojo
Journal:  J Pers Med       Date:  2020-11-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.